Market Cap 968.12M
Revenue (ttm) 76.99M
Net Income (ttm) -174.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -226.74%
Debt to Equity Ratio 0.44
Volume 9,447,300
Avg Vol 11,007,884
Day's Range N/A - N/A
Shares Out 636.92M
Stochastic %K 69%
Beta 0.69
Analysts Strong Sell
Price Target $3.69

Company Profile

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 650 473 7700
Address:
919 East Hillsdale Boulevard, Suite 250, Foster City, United States
ZoeyTanner
ZoeyTanner Jun. 26 at 9:39 PM
$GERN Dead money, lets count the ways....3 months=down 10% ; 6 months=down 54%; 1 year=down 66% ..chose your poison..you are dead $$$$$$$, and geron corporate parties like 1999..
0 · Reply
mikekhealy
mikekhealy Jun. 26 at 3:52 PM
$GERN If we ignore the noise from news and opinion pieces and focus solely on the chart ... there's a nice broadening formation leading back to $5+
0 · Reply
ZoeyTanner
ZoeyTanner Jun. 26 at 2:03 PM
$GERN How long will Bir drag out information she knows on combo trials for AML and MF with regard to fibrosis, changes in bone marrow and real improvement in disease modification?
0 · Reply
RedTop1
RedTop1 Jun. 26 at 1:20 PM
$ALT There goes my 100% gain. Reminds me of my 300% gain in $GERN. Im still bullish on both. Ok Bears! Today's the day to beat up on the Bulls, but remember! "The sun doesn't shine on the same dog all the time"! I'm hoping ALT goes into the 1's today so I can triple up my count!
0 · Reply
Fern64
Fern64 Jun. 25 at 8:35 PM
$GERN https://jadpro.com/online-first/2025/imetelstat-a-first-in-class-telomerase-inhibitor-for-the-treatment-of-patients-with-lower-risk-myelodysplastic-syndromes-and-anemia/
1 · Reply
omaromarp
omaromarp Jun. 25 at 4:17 PM
Next week will be an interesting test of Dawn's capabilities as a CEO. Q2 will be over and the company will have a good read on Q2 sales. If they are good (and based on April coming in 10% higher than March, they should be), Dawn will have the opportunity to pre-announce Q2 sales. If she doesn't then she is more of a sales/marketing type not a CEO. Geron is a small biotech, and there are limited opportunities to put out press releases between earnings calls. The ones on the horizon this year include an EU partner, UK approval, EU country agreements on pricing, possible clinical trial updates on AML and the MF combo trial, and possibly a new CEO. I've omitted a sale of the company because while that is possible, it is the ultimate press release and all others won't matter When you have an opportunity to flip the narrative with positive sales growth and beat analysts' estimates, it should be done ASAP rather than wait 5 weeks for the next earnings call. Credit tripsdad from ymb $GERN
0 · Reply
Mail_Dog
Mail_Dog Jun. 25 at 3:10 PM
$GERN Imo, in the absence of good news, this is what SHs can expect on a daily basis…
0 · Reply
ZoeyTanner
ZoeyTanner Jun. 25 at 1:33 PM
$GERN Naked shorty wants to play early
0 · Reply
Fern64
Fern64 Jun. 25 at 4:07 AM
$GERN https://sohoinsider.com/meetings-conferences/eha-2025/dr-komrokji-reports-imetelstat-data-in-high-epo-mds-from-eha-2025/
0 · Reply
meistermell
meistermell Jun. 24 at 11:29 PM
0 · Reply
Latest News on GERN
Conservative Vision Of A Positive Future For Geron

Jun 3, 2025, 9:57 AM EDT - 23 days ago

Conservative Vision Of A Positive Future For Geron


Geron Corporation (GERN) Q1 2025 Earnings Call Transcript

May 7, 2025, 12:50 PM EDT - 7 weeks ago

Geron Corporation (GERN) Q1 2025 Earnings Call Transcript


Geron Corp: How Concerned Should We Be About Rytelo Sales?

Mar 17, 2025, 5:19 PM EDT - 3 months ago

Geron Corp: How Concerned Should We Be About Rytelo Sales?


Geron Corporation Announces Departure of Chief Executive Officer

Mar 11, 2025, 4:02 PM EDT - 3 months ago

Geron Corporation Announces Departure of Chief Executive Officer


ZoeyTanner
ZoeyTanner Jun. 26 at 9:39 PM
$GERN Dead money, lets count the ways....3 months=down 10% ; 6 months=down 54%; 1 year=down 66% ..chose your poison..you are dead $$$$$$$, and geron corporate parties like 1999..
0 · Reply
mikekhealy
mikekhealy Jun. 26 at 3:52 PM
$GERN If we ignore the noise from news and opinion pieces and focus solely on the chart ... there's a nice broadening formation leading back to $5+
0 · Reply
ZoeyTanner
ZoeyTanner Jun. 26 at 2:03 PM
$GERN How long will Bir drag out information she knows on combo trials for AML and MF with regard to fibrosis, changes in bone marrow and real improvement in disease modification?
0 · Reply
RedTop1
RedTop1 Jun. 26 at 1:20 PM
$ALT There goes my 100% gain. Reminds me of my 300% gain in $GERN. Im still bullish on both. Ok Bears! Today's the day to beat up on the Bulls, but remember! "The sun doesn't shine on the same dog all the time"! I'm hoping ALT goes into the 1's today so I can triple up my count!
0 · Reply
Fern64
Fern64 Jun. 25 at 8:35 PM
$GERN https://jadpro.com/online-first/2025/imetelstat-a-first-in-class-telomerase-inhibitor-for-the-treatment-of-patients-with-lower-risk-myelodysplastic-syndromes-and-anemia/
1 · Reply
omaromarp
omaromarp Jun. 25 at 4:17 PM
Next week will be an interesting test of Dawn's capabilities as a CEO. Q2 will be over and the company will have a good read on Q2 sales. If they are good (and based on April coming in 10% higher than March, they should be), Dawn will have the opportunity to pre-announce Q2 sales. If she doesn't then she is more of a sales/marketing type not a CEO. Geron is a small biotech, and there are limited opportunities to put out press releases between earnings calls. The ones on the horizon this year include an EU partner, UK approval, EU country agreements on pricing, possible clinical trial updates on AML and the MF combo trial, and possibly a new CEO. I've omitted a sale of the company because while that is possible, it is the ultimate press release and all others won't matter When you have an opportunity to flip the narrative with positive sales growth and beat analysts' estimates, it should be done ASAP rather than wait 5 weeks for the next earnings call. Credit tripsdad from ymb $GERN
0 · Reply
Mail_Dog
Mail_Dog Jun. 25 at 3:10 PM
$GERN Imo, in the absence of good news, this is what SHs can expect on a daily basis…
0 · Reply
ZoeyTanner
ZoeyTanner Jun. 25 at 1:33 PM
$GERN Naked shorty wants to play early
0 · Reply
Fern64
Fern64 Jun. 25 at 4:07 AM
$GERN https://sohoinsider.com/meetings-conferences/eha-2025/dr-komrokji-reports-imetelstat-data-in-high-epo-mds-from-eha-2025/
0 · Reply
meistermell
meistermell Jun. 24 at 11:29 PM
0 · Reply
DAWGNuts
DAWGNuts Jun. 24 at 10:11 PM
$GERN https://www.facebook.com/share/p/1F3pZv25cK/
1 · Reply
DAWGNuts
DAWGNuts Jun. 24 at 10:08 PM
$GERN https://www.onclive.com/view/dr-mascarenhas-on-the-efficacy-of-imetelstat-plus-ruxolitinib-in-higher-risk-myelofibrosis?fbclid=IwY2xjawLIAD9leHRuA2FlbQIxMQABHvRNuI4i_btBct9qx698l-F9NoCgN7t6DyKXnKjyIUSTasw_qRz8zqIuagO-_aem_oYjC1SgcyCa9tezmeiHcIA
1 · Reply
dgreenway
dgreenway Jun. 24 at 3:34 PM
$GERN You know what is worse than the share price i have started to not give a shit anymore. I have been a shareholder since early 2018 and have added when its down like it is now and i refuse to add anymore.
1 · Reply
ZoeyTanner
ZoeyTanner Jun. 24 at 3:17 PM
$GERN How about a small wager on Geron performance for tomorrow, Wednesday 25. ?? One thing you can depend on is the swing trade crowd..Tomorrow down 5% or better.
1 · Reply
DAWGNuts
DAWGNuts Jun. 23 at 10:20 PM
$GERN California TV is airing some study about telomere length, cancers etc...nothing about Geron yet
2 · Reply
Find_the_Cure
Find_the_Cure Jun. 23 at 9:13 PM
$GERN what happened here?? approvals mean nothing apparently!!!
0 · Reply
Botwatson738
Botwatson738 Jun. 23 at 8:05 PM
$GERN Do everyone a favor and just get rid of the poison pill. Completely incompetent management team... Nearly 20 years and even with FDA approval, achieve a lower share price prior to the approval. Let some other company take over please.
0 · Reply
Mail_Dog
Mail_Dog Jun. 23 at 6:55 PM
$GERN Imo, this is what’s cooking at Co. HQ:
1 · Reply
JarvisFlow
JarvisFlow Jun. 23 at 10:30 AM
B. Riley Securities has updated their rating for Geron ( $GERN ) to Buy with a price target of 5.5.
1 · Reply
HahaYouSUCK
HahaYouSUCK Jun. 21 at 5:41 AM
$GERN GERN got the GERMS. Ain't nobody touching this bacteria infested company
1 · Reply
TheRealTraderMike
TheRealTraderMike Jun. 20 at 9:10 PM
0 · Reply
TheRealTraderMike
TheRealTraderMike Jun. 20 at 9:09 PM
$GERN trading at 6 soon. Big things coming up.
0 · Reply